Another study reported that MUC1-targeted CAR-T cells reduced the proliferation capability of esophageal cancer cells by activating the JAK/STAT pathway and inhibited tumor growth in transplantation models and patient-derived tumor xenograft (PDX) models of esophageal cancer in vivo (108). The gene discussed is MUC1; the disease is esophageal cancer.